[Kinetics of metipranolol in patients with chronic kidney failure and during hemodialysis].
The authors investigated the metipranolol plasma concentration in seven patients with renal failure after a single dose of 20 mg of the preparation (2 tablets of Trimepranol) by the oral route during haemodialysis and on days without dialysis, and evaluated also the effect of dialysis on selected pharmacokinetic constants. Although there was a great individual variability of plasma concentrations of metipranolol, these concentrations were at the end of dialysis lower than during the corresponding interval between dialyses. The mean values of the area beneath the concentration curve, the velocity elimination constants, the half-life of elimination and total clearance indicate a certain dialysability of metipranolol. During the practical application of these conclusions it is, however, important to consider the effect on blood pressure and cardiac rhythm resp. by changes of volume and the composition of the extracellular fluid caused by haemodialysis.
Motán
J
J
I. interní klinika lékarské fakulty UK, Plzen.
Mayer
O
O
Spanĕl
M
M
D000328:Adult; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism* / Q000628:therapy; D008297:Male; D014290:Metipranolol / Q000493:pharmacokinetics*; D008875:Middle Aged; D006435:Renal Dialysis
D014290:Metipranolol
Kinetika metipranololu u nemocných s chronickým selháním ledvin a v průbĕhu hemodialýzy.